Treatment-resistant depression affects four million Americans, and until now, patients have had almost no options. Dr. Steve Levine of Compass Pathways joins RTW's Stephanie Sirota to discuss COMP360, a psilocybin-based therapy for treatment-resistant depression. From the science behind rapid and durable response, to the regulatory path, reimbursement infrastructure, and what's next for PTSD, this is a rare inside look at how the most promising new chapter in psychiatric medicine gets built.

PODCAST TEAM

Producer & Director: Devon Leaver

Editor: Dominique Guerra

Production Coordinator: Ying Yu Lin

Production Support: Annabelle Chan

Research Consultant: Connor Williams

Executive Editorial Advisor: Stephanie Sirota

Theme Music: Yehezkel Raz

Additional Music: APM Music

 ...